News
Earnings Preview: Ormat Technologies (ORA) Q4 Earnings Expected to Decline
Ormat Technologies (ORA) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Kodiak Gas Services (KGS) Earnings Expected to Grow: Should You Buy?
The market expects Kodiak Gas Services (KGS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known
Lowe's (LOW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Lowe's (LOW) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
Heico Corporation (HEI) Earnings Expected to Grow: What to Know Ahead of Q1 Release
The market expects Heico Corporation (HEI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known
Dine Brands (DIN) Reports Next Week: Wall Street Expects Earnings Growth
The market expects Dine Brands (DIN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Salesforce.com (CRM) Earnings Expected to Grow: Should You Buy?
Salesforce.com (CRM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook
Earnings Preview: APA (APA) Q4 Earnings Expected to Decline
APA (APA) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good
APi (APG) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when APi (APG) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
BKV (BKV) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when BKV (BKV) reports results for the quarter ended December 2025. While this widely-known consensus outlook is
Bank of Montreal (BMO) Reports Next Week: Wall Street Expects Earnings Growth
Bank of Montreal (BMO) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus
Earnings Preview: Permian Resources (PR) Q4 Earnings Expected to Decline
The market expects Permian Resources (PR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Analysts Estimate SM Energy (SM) to Report a Decline in Earnings: What to Look Out for
SM Energy (SM) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a
Arhaus, Inc. (ARHS) Expected to Beat Earnings Estimates: Should You Buy?
The market expects Arhaus, Inc. (ARHS) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Earnings Preview: C3.ai, Inc. (AI) Q3 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when C3.ai, Inc. (AI) reports results for the quarter ended January 2026. While this widely-known consensus outlook is
Excelerate Energy (EE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Excelerate Energy (EE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook
Earnings Preview: Acadia Healthcare (ACHC) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Acadia Healthcare (ACHC) reports results for the quarter ended December 2025. While this widely-known consensus
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Acadia Pharmaceuticals (ACAD) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus
Analysts Estimate Marriott Vacations Worldwide (VAC) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Marriott Vacations Worldwide (VAC) reports results for the quarter ended December 2025. While this widely-known
Sabre (SABR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabre (SABR) reported $666.53 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 6.7%. EPS of -$0.01 for the same period compares to -$0.08 a year ago.
Clean Harbors (CLH) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Clean Harbors (CLH) reported revenue of $1.5 billion, up 4.8% over the same period last year. EPS came in at $1.62, compared to $1.55 in the year-ago quarter.
Best Momentum Stocks to Buy for February 18th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 18:
Celestica Inc. CLS: This hardware platform provider and supply chain solutions
Wall Street Analysts Think Oatly Group (OTLY) Could Surge 57.13%: Read This Before Placing a Bet
Oatly Group AB Sponsored ADR (OTLY) closed the last trading session at $11.71, gaining 13.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Believe Nvidia (NVDA) Could Rally 38.16%: Here's is How to Trade
Nvidia (NVDA) closed the last trading session at $184.97, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Karyopharm Therapeutics (KPTI) Could Rally 56.06%: Here's is How to Trade
Karyopharm Therapeutics (KPTI) closed the last trading session at $9.4, gaining 58% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Wall Street Analysts Think Sonos (SONO) Could Surge 28.21%: Read This Before Placing a Bet
Sonos (SONO) closed the last trading session at $15.6, gaining 1.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street